FDA UDI
In Commercial Distribution
🇺🇸 United States
QuantiFERON-TB Gold 2 Plate Kit
DI: 04053228002109
·
Model: 1
·
QIAGEN SCIENCES INC.
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1
Let the assistant research this device
The Research Assistant compiles product codes, classification, clearances and adverse events for this device — and cites every record.
Free to try · every answer cites its records
Basic Information
- Brand Name
- QuantiFERON-TB Gold 2 Plate Kit
- Primary DI
- 04053228002109
- Version / Model
- 1
- Catalog Number
- 5940201
- Company Name
- QIAGEN SCIENCES INC.
- Labeler DUNS
- 008675485
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 1
- Record Status
- Published
- Publish Date
- 2017-01-04
- Public Version
- 5
- Public Version Date
- 2022-03-08
- Public Version Status
- Update
- Public Device Record Key
- 793a3dfa-46cf-4015-b410-5efd4beec785
Device Characteristics
- Single Use
- No
- Prescription Use (Rx)
- Yes
- Over the Counter (OTC)
- No
- Kit
- Yes
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- No
- Has Lot/Batch Number
- Yes
- Has Manufacturing Date
- No
- Has Expiration Date
- Yes
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| NCD | Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis | Unknown | 3 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 60744 | Interferon gamma release IVD, kit, enzyme immunoassay (EIA) | A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of interferon gamma (IFN gamma) released in response to T-cell activation resulting from stimulation by one or multiple specific antigens or mitogens, using an enzyme immunoassay (EIA) method. It is typically used as an indirect marker of infection for (but not limited to) Borrelia species, Epstein-Barr virus (EBV), Cytomegalovirus (CMV), BK virus, severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2), and/or Mycobacterium species. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Primary | 04053228002109 | GS1 |
Premarket Submissions
| Submission Number | Supplement Number |
|---|---|
| P010033 | 000 |